(2R)-1-[(2-Methyl-2-propanyl)amino]-3-{[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy}-2-propanol (2Z)-2-butenedioate (1:1)(CAS: 26839-77-0)

The compound (2R)-1-[(2-Methyl-2-propanyl)amino]-3-{[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy}-2-propanol (2Z)-2-butenedioate (1:1) (CAS: 26839-77-0) should comply with GHS classification for hazardous chemicals, REACH regulations for EU markets, and FDA/EPA requirements for food and pharmaceutical applications. Specific handling and storage guidelines should be followed based on its potential hazards and intended use.

Alternatives to (2R)-1-[(2-Methyl-2-propanyl)amino]-3-{[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy}-2-propanol (2Z)-2-butenedioate (1:1) (CAS: 26839-77-0) include other thiadiazoles with different substituents or related amine compounds. Common alternatives involve using morpholine derivatives or isomeric thiadiazoles that offer similar functional groups and properties.

The market and research trends for (2R)-1-[(2-Methyl-2-propanyl)amino]-3-{[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy}-2-propanol (2Z)-2-butenedioate (1:1) (CAS: 26839-77-0) are driven by its potential applications in pharmaceuticals and organic synthesis. Research is focusing on its use as a precursor in drug discovery and development, with a growing interest in its synthetic capabilities and reactivity.

Waste containing (2R)-1-[(2-Methyl-2-propanyl)amino]-3-{[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy}-2-propanol (2Z)-2-butenedioate (1:1) (CAS: 26839-77-0) should be collected in appropriate containers, labeled with the hazard information, and handled according to the GHS guidelines. Disposal should be conducted through professional waste management facilities to ensure safe and environmentally friendly processes. Proper environmental precautions should be taken to minimize any potential contamination.